二肽基肽酶4抑制剂/二甲双胍固定剂量复方制剂的临床应用专家建议

2020-12-30 中华医学会内分泌学分会 中华糖尿病杂志.2020.12(12):949-953.

二肽基肽酶4(DPP‑4)抑制剂和二甲双胍联合应用,针对2型糖尿病不同的病理生理缺陷发挥机制互补、协同增效的降糖作用。DPP‑4抑制剂/二甲双胍固定剂量复方制剂(FDC)和等剂量DPP‑4抑制剂、二甲

中文标题:

二肽基肽酶4抑制剂/二甲双胍固定剂量复方制剂的临床应用专家建议

发布日期:

2020-12-30

简要介绍:

二肽基肽酶4(DPP‑4)抑制剂和二甲双胍联合应用,针对2型糖尿病不同的病理生理缺陷发挥机制互补、协同增效的降糖作用。DPP‑4抑制剂/二甲双胍固定剂量复方制剂(FDC)和等剂量DPP‑4抑制剂、二甲双胍自由联合相比,具有良好的生物等效性。与两种药物自由联合相比,FDC可简化治疗方案,提高患者治疗依从性。笔者重点围绕DPP‑4抑制剂/二甲双胍FDC的有效性和安全性、优势和局限性、适用人群以及使用注意事项等提出建议。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=968241, encodeId=a51096824106, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef8a5466242, createdName=ms5000002068964342, createdTime=Mon May 24 21:12:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947226, encodeId=8e1c94e226ee, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fbc5466667, createdName=ms8000001438846519, createdTime=Wed Mar 10 20:12:36 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947224, encodeId=b0bd94e2247a, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fbc5466667, createdName=ms8000001438846519, createdTime=Wed Mar 10 20:05:07 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923005, encodeId=79c2923005f2, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77b2949953, createdName=584199593, createdTime=Fri Feb 05 11:17:01 CST 2021, time=2021-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922032, encodeId=57149220328b, content=二肽基肽酶抑制剂二甲双胍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc115448783, createdName=ms1000002016287811, createdTime=Mon Feb 01 21:00:16 CST 2021, time=2021-02-01, status=1, ipAttribution=)]
    2021-05-24 ms5000002068964342

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=968241, encodeId=a51096824106, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef8a5466242, createdName=ms5000002068964342, createdTime=Mon May 24 21:12:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947226, encodeId=8e1c94e226ee, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fbc5466667, createdName=ms8000001438846519, createdTime=Wed Mar 10 20:12:36 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947224, encodeId=b0bd94e2247a, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fbc5466667, createdName=ms8000001438846519, createdTime=Wed Mar 10 20:05:07 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923005, encodeId=79c2923005f2, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77b2949953, createdName=584199593, createdTime=Fri Feb 05 11:17:01 CST 2021, time=2021-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922032, encodeId=57149220328b, content=二肽基肽酶抑制剂二甲双胍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc115448783, createdName=ms1000002016287811, createdTime=Mon Feb 01 21:00:16 CST 2021, time=2021-02-01, status=1, ipAttribution=)]
    2021-03-10 ms8000001438846519

    好指南

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=968241, encodeId=a51096824106, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef8a5466242, createdName=ms5000002068964342, createdTime=Mon May 24 21:12:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947226, encodeId=8e1c94e226ee, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fbc5466667, createdName=ms8000001438846519, createdTime=Wed Mar 10 20:12:36 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947224, encodeId=b0bd94e2247a, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fbc5466667, createdName=ms8000001438846519, createdTime=Wed Mar 10 20:05:07 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923005, encodeId=79c2923005f2, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77b2949953, createdName=584199593, createdTime=Fri Feb 05 11:17:01 CST 2021, time=2021-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922032, encodeId=57149220328b, content=二肽基肽酶抑制剂二甲双胍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc115448783, createdName=ms1000002016287811, createdTime=Mon Feb 01 21:00:16 CST 2021, time=2021-02-01, status=1, ipAttribution=)]
    2021-03-10 ms8000001438846519

    好指南

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=968241, encodeId=a51096824106, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef8a5466242, createdName=ms5000002068964342, createdTime=Mon May 24 21:12:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947226, encodeId=8e1c94e226ee, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fbc5466667, createdName=ms8000001438846519, createdTime=Wed Mar 10 20:12:36 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947224, encodeId=b0bd94e2247a, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fbc5466667, createdName=ms8000001438846519, createdTime=Wed Mar 10 20:05:07 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923005, encodeId=79c2923005f2, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77b2949953, createdName=584199593, createdTime=Fri Feb 05 11:17:01 CST 2021, time=2021-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922032, encodeId=57149220328b, content=二肽基肽酶抑制剂二甲双胍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc115448783, createdName=ms1000002016287811, createdTime=Mon Feb 01 21:00:16 CST 2021, time=2021-02-01, status=1, ipAttribution=)]
    2021-02-05 584199593

    实用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=968241, encodeId=a51096824106, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef8a5466242, createdName=ms5000002068964342, createdTime=Mon May 24 21:12:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947226, encodeId=8e1c94e226ee, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fbc5466667, createdName=ms8000001438846519, createdTime=Wed Mar 10 20:12:36 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947224, encodeId=b0bd94e2247a, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fbc5466667, createdName=ms8000001438846519, createdTime=Wed Mar 10 20:05:07 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923005, encodeId=79c2923005f2, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77b2949953, createdName=584199593, createdTime=Fri Feb 05 11:17:01 CST 2021, time=2021-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922032, encodeId=57149220328b, content=二肽基肽酶抑制剂二甲双胍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc115448783, createdName=ms1000002016287811, createdTime=Mon Feb 01 21:00:16 CST 2021, time=2021-02-01, status=1, ipAttribution=)]
    2021-02-01 ms1000002016287811

    二肽基肽酶抑制剂二甲双胍

    0